Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 321 participants.
Also called NCT04580914
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 321 participants
- Sponsor
- Registry
-
NCT04580914
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Belgium, Canada, France, Germany, Hong Kong SAR China, Italy, Japan, Monaco, Netherlands, Taiwan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04580914. Allocation not applicable; no masking; primary purpose treatment. Start 2021-04-12 (actual); primary completion 2023-06-21 (actual). Results posted on 2025-01-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation
- Acronym
- NEwTON AF
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Treatment with IntellaNav StablePoint Ablation Catheter
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct04580914- Content hash
b304af583484ac8c18428211939c27610cab35257e107b455733377de3fd8615